Lipella Pharmaceuticals Inc. Increase (Decrease) in Accrued Liabilities
Lipella Pharmaceuticals Inc. (LIPO) reported Increase (Decrease) in Accrued Liabilities of -$202.95 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $19.85K.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$243.22K, a 678.14% decline year-over-year.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $20.42K, a 167.00% increase year-over-year.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $148.12K, a 12191.78% increase year-over-year.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $160.61K.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$315.52K, a 232.75% decline from fiscal 2022.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $237.69K, a 56.87% increase from fiscal 2021.
- Lipella Pharmaceuticals Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $151.52K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $19.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$223.37K derived: sum of 2 quarters · filed 2025-11-14 | -$202.95K 10-Q · filed 2025-11-14 | -$54.83K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | -$243.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$222.80K 10-Q · filed 2025-08-14 | -$74.68K derived: sum of 3 quarters · filed 2025-08-14 | -$111.91K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-03-31 | $20.42K 10-Q · filed 2025-05-14 | $168.54K derived: sum of 2 quarters · filed 2025-05-14 | $131.31K derived: sum of 3 quarters · filed 2025-11-14 | $173.38K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-12-31 | $148.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $110.89K derived: sum of 2 quarters · filed 2025-11-14 | $152.96K derived: sum of 3 quarters · filed 2025-11-14 | $160.61K 10-K · filed 2025-03-28 | |
| 2024-09-30 | -$37.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $4.84K derived: sum of 2 quarters · filed 2025-11-14 | $12.49K 10-Q · filed 2025-11-14 | $12.49K 10-Q · filed 2024-11-14 | $13.70K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $42.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $49.72K 10-Q · filed 2025-08-14 | $50.92K derived: sum of 3 quarters · filed 2025-08-14 | -$11.71K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $7.65K 10-Q · filed 2025-05-14 | $8.85K derived: sum of 2 quarters · filed 2025-05-14 | -$53.77K derived: sum of 3 quarters · filed 2025-05-14 | -$99.86K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.21K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$61.42K derived: sum of 2 quarters · filed 2025-03-28 | -$107.51K derived: sum of 3 quarters · filed 2025-03-28 | -$315.52K 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$62.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$108.71K derived: sum of 2 quarters · filed 2024-11-14 | -$316.73K 10-Q · filed 2024-11-14 | -$125.22K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$46.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$254.10K 10-Q · filed 2024-08-13 | -$62.59K derived: sum of 3 quarters · filed 2024-08-13 | -$163.33K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$208.02K 10-Q · filed 2024-05-09 | -$16.51K derived: sum of 2 quarters · filed 2024-05-09 | -$117.25K derived: sum of 3 quarters · filed 2024-05-09 | $17.38K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $191.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $90.77K derived: sum of 2 quarters · filed 2024-02-27 | $225.40K derived: sum of 3 quarters · filed 2024-02-27 | $237.69K 10-K · filed 2024-02-27 | |
| 2022-09-30 | -$100.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $33.89K derived: sum of 2 quarters · filed 2023-11-14 | $46.18K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $134.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $146.92K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $12.29K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $151.52K 10-K · filed 2023-03-31 |